Doctor profile · Federal record
Dr. Samer Suki, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Kingwood, TX
- NPI 1639132962
- Accepts Medicare
- MIPS 73.5 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
22710 Professional Dr
Kingwood, TX 773396008
(281) 298-8444
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- February 18, 2022
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Texas #J0686
- Medicaid
- TX #136501707
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639132962. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
183,383
Distinct HCPCS
10
Medicare allowed
$2,109,678
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 54,750 | 31 | $1 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 39,000 | 12 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 18,000 | 13 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 16,800 | 16 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 12,840 | 46 | $23 | |
A9575 |
Injection, gadoterate meglumine, 0.1 ml | 11,900 | 50 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 9,700 | 78 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,800 | 15 | $3 | |
88185 |
Flow cytometry technique for dna or cell analysis, each additional marker | 2,269 | 72 | $24 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,070 | 34 | $0 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 3,885. This provider delivers 47× the peer median.Open Payments
Industry payments received
All-time total
$3,351
Transactions
92
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| US Oncology Corporate, Inc. | 2 | $381.02 | |
| AstraZeneca Pharmaceuticals LP | 6 | $272.30 | |
| Daiichi Sankyo Inc. | 9 | $215.84 | |
| PFIZER INC. | 13 | $200.99 | |
| Celgene Corporation | 7 | $191.14 | |
| ABBVIE INC. | 7 | $167.35 | |
| Astellas Pharma US Inc | 5 | $166.86 | |
| SpringWorks Therapeutics, Inc. | 9 | $157.30 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $139.16 | |
| Janssen Biotech, Inc. | 6 | $137.72 | |
| Novartis Pharmaceuticals Corporation | 6 | $114.44 | |
| GENZYME CORPORATION | 4 | $106.38 | |
| GlaxoSmithKline, LLC. | 5 | $93.76 | |
| Eisai Inc. | 5 | $90.18 | |
| Gilead Sciences, Inc. | 4 | $75.03 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,057
Patients
360
Total drug cost
$173,082
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 136 | 39 | $4,229 |
| Levothyroxine Sodium | Generic | 111 | 27 | $962 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 88 | 32 | $2,641 |
| Ondansetron Hcl | Generic | 80 | 49 | $1,162 |
| Xarelto (Rivaroxaban) | Brand | 80 | 19 | $78,950 |
| Hydroxyurea | Generic | 73 | 17 | $4,405 |
| Eliquis (Apixaban) | Brand | 69 | 18 | $74,873 |
| Dexamethasone | Generic | 64 | 34 | $1,410 |
| Warfarin Sodium | Generic | 63 | 0 | $837 |
| Pantoprazole Sodium | Generic | 57 | 20 | $692 |
Hospital affiliations
Frequently asked questions
What is Dr. Samer Suki's medical specialty?
Dr. Samer Suki practices Hematology & Oncology Physician in Kingwood, TX.
Where does Dr. Samer Suki practice?
Dr. Samer Suki practices at 22710 Professional Dr, Kingwood, TX 773396008. Office phone: 2812988444.
What is Dr. Samer Suki's NPI?
Dr. Samer Suki's National Provider Identifier (NPI) is 1639132962, issued by NPPES.
Does Dr. Samer Suki accept Medicare assignment?
Yes. Dr. Samer Suki accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samer Suki commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.